Cargando…
How to make the best of NLRP3 inhibitors in patients with COVID-19?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250839/ https://www.ncbi.nlm.nih.gov/pubmed/37294339 http://dx.doi.org/10.1007/s00228-023-03518-z |
| _version_ | 1785055843472900096 |
|---|---|
| author | Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad |
| author_facet | Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad |
| author_sort | Kow, Chia Siang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10250839 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102508392023-06-12 How to make the best of NLRP3 inhibitors in patients with COVID-19? Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad Eur J Clin Pharmacol Correspondence Springer Berlin Heidelberg 2023-06-09 /pmc/articles/PMC10250839/ /pubmed/37294339 http://dx.doi.org/10.1007/s00228-023-03518-z Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correspondence Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad How to make the best of NLRP3 inhibitors in patients with COVID-19? |
| title | How to make the best of NLRP3 inhibitors in patients with COVID-19? |
| title_full | How to make the best of NLRP3 inhibitors in patients with COVID-19? |
| title_fullStr | How to make the best of NLRP3 inhibitors in patients with COVID-19? |
| title_full_unstemmed | How to make the best of NLRP3 inhibitors in patients with COVID-19? |
| title_short | How to make the best of NLRP3 inhibitors in patients with COVID-19? |
| title_sort | how to make the best of nlrp3 inhibitors in patients with covid-19? |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250839/ https://www.ncbi.nlm.nih.gov/pubmed/37294339 http://dx.doi.org/10.1007/s00228-023-03518-z |
| work_keys_str_mv | AT kowchiasiang howtomakethebestofnlrp3inhibitorsinpatientswithcovid19 AT ramachandramdineshsangarran howtomakethebestofnlrp3inhibitorsinpatientswithcovid19 AT hasansyedshahzad howtomakethebestofnlrp3inhibitorsinpatientswithcovid19 |